Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Clinical trials
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Emerging Pharmacological Treatment in Nonalcoholic Steatohepatitis
Available to Purchase
Journal:
Visceral Medicine
Visc Med (2020) 36 (5): 411–416.
Published Online: 05 May 2020
.... Nonalcoholic fatty liver disease Clinical trials Nonalcoholic steatohepatitis Metabolic liver disease End-stage liver disease Pharmacotherapy Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease globally. Nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH...
Journal Articles
Precision Medicine and Non-Colorectal Cancer Liver Metastases: Fiction or Reality?
Available to Purchase
Journal:
Visceral Medicine
Viszeralmedizin (2015) 31 (6): 434–439.
Published Online: 04 December 2015
.... Results: In order to best characterize and track tumor biological behaviors as well as to understand mechanisms of response to therapy and survival we suggest the application of novel clinical trial designs, a dynamic approach with serial monitoring involving evaluation of primary and metastatic sites...